The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number PB2013-101510
Title Review of Medicare Outpatient Billing for Selected Drugs at Essentia Health Duluth.
Publication Date Aug 2012
Media Count 16p
Personal Author N/A
Abstract Essentia Health Duluth (Essentia) is an acute-care hospital located in Duluth, Minnesota. Based on data analysis, we reviewed $1,261,769 in Medicare payments to Essentia for 131 line items for injections of selected drugs that Essentia billed to Medicare during our audit period (January 1, 2008, through April 30, 2011). These line items consisted of injections for baclofen, infliximab, trastuzumab, rituximab, bortezomib, immune globulin, bevacizumab, epoetin alfa, and paclitaxel. Our objective was to determine whether Essentia billed Medicare for injections of selected drugs in accordance with Federal requirements.
Keywords Audits
Essentia Health Duluth
Federal requirements
Incorrect billing
Injectable drugs
Outpatient claims
Prescription drugs

Source Agency Department of Health and Human Services, Washington, DC
NTIS Subject Category 44Q - Health Related Costs
57Q - Pharmacology & Pharmacological Chemistry
Corporate Author Department of Health and Human Services, Washington, DC. Office of the Inspector General.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1303
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader